Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |